anti mouse cd38 pe vio770 (Miltenyi Biotec)
Miltenyi Biotec is a verified supplier 
Miltenyi Biotec manufactures this product 
93
Structured Review
Miltenyi Biotec
anti mouse cd38 pe vio770
Anti Mouse Cd38 Pe Vio770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd38/CD38+Antibody%2C+anti-mouse/pmc13337242-96-3-7
Average 93 stars, based on 10 article reviews
Anti Mouse Cd38 Pe Vio770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd38/CD38+Antibody%2C+anti-mouse/pmc13337242-96-3-7
Average 93 stars, based on 10 article reviews
anti mouse cd38 pe vio770 - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
other:Article Title: Exercise-mobilized lymphocytes enhance antibody-based immunotherapy in multiple myeloma through CD16 + NK cell-mediated cytotoxicity. Article Snippet: Surface and intracellular staining on lymphocytes and tumors Frozen PBMCs were thawed and pretreated for 24 h with daratumumab or magrolimab (10 μg/mL; Selleckchem, USA), lenalidomide (2 μM; Selleckchem, USA), and dexamethasone (50 Flow Cytometry:Article Title: Temporal Genomic Dynamics Shape Clinical Trajectory in Multiple Myeloma Article Snippet: Tumor cells from diagnostic samples were isolated from diagnostic samples by CD138 magnetic beads using either a QuadroMACS separator and LS column-based method (CD138 MicroBeads, human, Mylteni Biotec, USA) or a RobosepTM approach (EasySepTM Human CD138 Positive Selection Kit II, Stemcell, Canada) according to manufacturer’s instruction. .. Tumor cells from follow-up samples were sorted by flow cytometry based on the expression of Expressing:Article Title: Temporal Genomic Dynamics Shape Clinical Trajectory in Multiple Myeloma Article Snippet: Tumor cells from diagnostic samples were isolated from diagnostic samples by CD138 magnetic beads using either a QuadroMACS separator and LS column-based method (CD138 MicroBeads, human, Mylteni Biotec, USA) or a RobosepTM approach (EasySepTM Human CD138 Positive Selection Kit II, Stemcell, Canada) according to manufacturer’s instruction. .. Tumor cells from follow-up samples were sorted by flow cytometry based on the expression of FACS:Article Title: Temporal Genomic Dynamics Shape Clinical Trajectory in Multiple Myeloma Article Snippet: Tumor cells from diagnostic samples were isolated from diagnostic samples by CD138 magnetic beads using either a QuadroMACS separator and LS column-based method (CD138 MicroBeads, human, Mylteni Biotec, USA) or a RobosepTM approach (EasySepTM Human CD138 Positive Selection Kit II, Stemcell, Canada) according to manufacturer’s instruction. .. Tumor cells from follow-up samples were sorted by flow cytometry based on the expression of Staining:Article Title: Early-stage B cells predict relapse after rituximab treatment in patients with Membranous Nephropathy Article Snippet: .. To characterize B-cell subsets, peripheral blood mononuclear cells were stained with fluorochrome-conjugated monoclonal antibodies (BD Biosciences) directed against the following antigens: CD45 (V500-C), CD3 (APC), CD19 (APC-H7), CD27 (BV421), IgD (PE), Article Title: Early-Stage B-cells Predict Relapse After Rituximab Treatment in Patients With Membranous Nephropathy Article Snippet: .. To characterize B-cell subsets, peripheral blood mononuclear cells were stained with fluorochrome-conjugated monoclonal antibodies (BD Biosciences) directed against the following antigens: CD45 (V500-C), CD3 (APC), CD19 (APC-H7), CD27 (BV421), IgD (PE), Bioprocessing:Article Title: Early-stage B cells predict relapse after rituximab treatment in patients with Membranous Nephropathy Article Snippet: .. To characterize B-cell subsets, peripheral blood mononuclear cells were stained with fluorochrome-conjugated monoclonal antibodies (BD Biosciences) directed against the following antigens: CD45 (V500-C), CD3 (APC), CD19 (APC-H7), CD27 (BV421), IgD (PE), Article Title: Early-Stage B-cells Predict Relapse After Rituximab Treatment in Patients With Membranous Nephropathy Article Snippet: .. To characterize B-cell subsets, peripheral blood mononuclear cells were stained with fluorochrome-conjugated monoclonal antibodies (BD Biosciences) directed against the following antigens: CD45 (V500-C), CD3 (APC), CD19 (APC-H7), CD27 (BV421), IgD (PE), |
